https://www.selleckchem.com/products/azd4547.html
https://www.selleckchem.com/products/azd4547.html
FOXO3a and Posttranslational Modifications Mediate Glucocorticoid Awareness within B-ALL. Older patients with early breast cancer (EBC) derive modest survival benefit from chemotherapy but have increased toxicity risk. Data on the impact of chemotherapy for EBC on quality of life in older patients are limited, but this is a key determinant of treatment acceptance. We aimed to investigate its effect on quality of life in older patients enrolled in the Bridging the Age Gap study. A p
Like
Comment
Share
